Cartesian Therapeutics (RNAC)

• Market cap: $188M
• 1 day: -1.9%
• 5 days: -15.36%
• 1 month: 0.98%
• 3 months: -23.52%
• 6 months: -26.02%
• Year to date: -57.35%
• 1 year: -62.53%
• 5 years: -92.16%
• 10 years: -98.28%
• Sector: Healthcare
• Industry: Biotechnology

About: Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Employees: 66